$MGPI

MGP Ingredients (NASDAQ:MGPI) misses Q3 2026 revenue estimates

MGP Ingredients reported Q3 2026 revenue of $117.9 million, missing estimates by 2.2%, but beat EPS estimates by 21.1%. Adjusted EBITDA missed slightly. Full-year guidance was reconfirmed, with EBITDA expected to exceed estimates. Operating margin declined, while free cash flow margin improved.

Original reporting
Published Oct 28, 2026, 11:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MGP Ingredients (NASDAQ:MGPI) misses Q3 2026 revenue estimates — source image
Decision brief

The 30-second read

$MGPINeutralMed
01

Why it matters

Revenue missed and operating margin declined year over year, but adjusted EPS beat and full-year revenue and EPS guidance were reconfirmed; EBITDA guidance was also above consensus at the midpoint.

02

Market read

Traders will likely reassess near-term demand and margin trajectory while using reconfirmed guidance to frame downside risk.

03

What to watch

Operating margin fell to 10.2% from 16.1% year over year, so traders may underweight cost normalization risk even with free cash flow margin improving.

Relevance 7/10Novelty 7/10Timing: post-earnings coverage, same-day reaction implied

Background

The piece summarizes MGP Ingredients’ Q3 2026 results versus S&P analysts’ consensus and reiterates full-year guidance.

Company-level read

Ticker impact

$MGPINeutralMedium confidence
Context

MGP Ingredients reported Q3 2026 revenue of $117.9M, missing consensus $120.6M, while adjusted EPS beat at $0.39 and EBITDA slightly missed.

Expected impact

Likely choppy trading as the market weighs the revenue miss against the EPS beat and the reaffirmed full-year revenue/EPS guidance.

Evidence & confidence

The article provides a clear revenue miss versus consensus, but also shows EPS outperformance and guidance reconfirmation, which can limit downside despite weaker operating margin.

Market effects

Signals demand and margin pressure dynamics for food ingredients producers, with investors focusing on operating margin deterioration versus cash generation.

No specific regional spillover indicated beyond US-listed consumer/food-ingredient sentiment.

Limited global relevance; impacts are primarily company-specific within the US ingredients market.

Counterpoint

The revenue miss may be less important if the company’s cash flow strength and reconfirmed full-year revenue/EPS guidance indicate the quarter was timing-related rather than structural.

Key entities

  • MGP Ingredients

    US-listed ingredients producer reporting Q3 2026 results and reconfirmed full-year guidance.

Related articles

$MGPIMed

MGP Ingredients Reports Q3 Sales of $117.9 Million, Reaffirms 2026 Outlook

MGP Ingredients reported Q3 2026 sales of $117.9M, down 10% YoY, with net income of $6.9M. Adjusted EPS was $0.39, down from $0.85. The company reaffirmed its 2026 outlook and announced a name change to Sempreon on November 2. Sales growth was seen in Penelope Bourbon and mid-priced brands, while Distilling Solutions faced market challenges. Ingredient Solutions saw growth in specialty wheat proteins.

$MGPIMed

MGP Ingredients Reports Third Quarter 2026 Results

MGP INGREDIENTS INC (MGPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. MGP Ingredients Reports Third Quarter 2026 Results Company reaffirms full-year 2026 guidance, declares $0.12 quarterly dividend and will become Sempreon, Inc. (Nasdaq: CASK) on November 2 ATCHISON, Kan., October 28, 2026 - MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider

$MGPIMedAI 8/10

A bourbon brand's sales rose 12% as MGP Ingredients' total sales fell 10%.

MGP Ingredients reported a 10% decline in total sales for Q3 2026, with Branded Spirits sales down 4% and Distilling Solutions sales down 29%. Penelope Bourbon sales rose 12%. Gross profit fell 18% to $40.5M. The company reaffirmed its 2026 guidance, expecting sales of $480M-$500M and adjusted EBITDA of $82M-$90M. MGP will change its name to Sempreon, Inc. and ticker to CASK on November 2, 2026.

$TSNHigh

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills Shares Are Falling, What You Need To Know

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills shares fell due to U.S. cattle shortages and margin pressures. Tyson cut its 2026 adjusted operating income outlook to $2.1B-$2.3B, citing beef-segment losses. The company is closing plants and exploring sales to restructure. Other firms also saw declines. Tyson's stock is down 11% YTD and 24.8% from its 52-week high.